CareCloud announced that the Heart & Vascular Institute has selected CareCloud’s chronic care management, CCM, program to empower patients with chronic conditions to take control of their health. CareCloud’s program provides personalized care plans, remote monitoring, and regular check-ins with healthcare providers to help improve patient outcomes, reduce healthcare costs, and streamline operations at the Institute. "CCM services provide ongoing support and care coordination to patients with chronic conditions, resulting in improved patient outcomes, increased patient satisfaction, and reduced healthcare costs," said Dr. Iram Fatima, chief operating officer of electronic health records and digital health at CareCloud. "With regular communication between patients and healthcare providers through CCM programs, potential health issues can be identified and resolved before they turn into more serious problems, improving medication adherence and leading to better
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on CCLD:
- Heart & Vascular Institute Selects CareCloud’s Chronic Care Management Program to Empower Patients with Personalized Care Plans and Improve Health Outcomes
- CareCloud’s medSR Division to Exhibit at Becker’s Annual Meeting
- Hadi Chaudhry, the CEO and President of CareCloud, Recognized as a Top 10 Dynamic Business Leader in 2023 by Mirror Review
- CareCloud to Present at the KeyBanc Life Sciences & MedTech Investor Forum
- CareCloud Operations Unaffected by Shutdown of Silicon Valley Bank